Welcome and introduction (ID 4765)
Biomarkers for treatment with immune checkpoint inhibitors. Where are we now? (ID 4766)
Efficacy and safety of immune checkpoint inhibitors in patients with dMMR/MSI-H advanced/recurrent endometrial cancer (ID 4767)
Efficacy and safety of immune checkpoint inhibitors in patients with dMMR/MSI-H solid tumors (ID 4768)
Patient case report panel discussion: Biomarkers in pan tumor treatment (ID 4769)
